1989
DOI: 10.1016/0046-8177(89)90070-1
|View full text |Cite
|
Sign up to set email alerts
|

Malignant giant cell tumor of synovium and locally destructive pigmented villonodular synovitis: Ultrastructural and immunohistochemical study and review of the literature

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
30
0
2

Year Published

1991
1991
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 68 publications
(32 citation statements)
references
References 22 publications
0
30
0
2
Order By: Relevance
“…The most consistent genetic rearrangement in both localized and diffuse types of PVNS is in chromosome 1p11-13, a site for CSF-1 gene, which most commonly fuses to COL6a3 on chromosome 2q35 (34,35). Trisomy of chromosomes 5 and 7 has also been reported in diffuse and malignant PVNS (8,36). These cytogenetic aberrations are seen in the majority but not all cases of PVNS.…”
Section: Pathologic Featuresmentioning
confidence: 88%
“…The most consistent genetic rearrangement in both localized and diffuse types of PVNS is in chromosome 1p11-13, a site for CSF-1 gene, which most commonly fuses to COL6a3 on chromosome 2q35 (34,35). Trisomy of chromosomes 5 and 7 has also been reported in diffuse and malignant PVNS (8,36). These cytogenetic aberrations are seen in the majority but not all cases of PVNS.…”
Section: Pathologic Featuresmentioning
confidence: 88%
“…9 However, their capacity for a certain degree of autonomous growth, local recurrence if inadequately excised and rarely metastasis speaks strongly for a neoplastic theory. 4,16,17 Although histomorphologically similar, TGCT-D, TGCT-L and PVNS differ in their clinical and biologic behavior and should not be used as synonyms. 2,8,14 TGCT-L may occur at any age but is most often seen in the third to fifth decades with a slight female predominance, unlike the younger age group, which is affected in TGCT-D and PVNS.…”
Section: Discussionmentioning
confidence: 99%
“…Only 37 malignant tenosynovial GCTs have been reported in the literature since 1979, and these are summarized in ►Tables 1-3. [3][4][5][6][7][8][9][10][11][12][13][14][15][16][17] Of these 37 patients, follow-up outcome was known in 30 patients; one patient had died of other causes (DOC). Of the remaining 29 patients, 11 patients died of disease (DOD), 4 patients were living with disease (LWD) and 14 patients had no evidence of disease (NED) since their last treatment, with a follow-up of 6 months to 49 years.…”
Section: Discussionmentioning
confidence: 99%